[
  {
    "title": "Capturing electronic patient reported outcomes in oncology practice. - ASCO Publications",
    "url": "https://ascopubs.org/doi/10.1200/OP.2025.21.10_suppl.391",
    "summary": [
      {
        "type": "bullet",
        "text": "**KEY FINDING**: 67% of patients completed assessments with auto-reminders, halving discontinuation risk."
      },
      {
        "type": "bullet",
        "text": "**TACTICAL WIN [ROADMAP]**: Develop AI-driven patient prioritization to optimize reminder timing."
      },
      {
        "type": "bullet",
        "text": "**MARKET SIGNAL [ðŸŸ¡ NOTABLE]**: Growing adoption trend shows PROs improving trial success rates by 25%."
      },
      {
        "type": "bullet",
        "text": "**CONCERN**: Self-selection bias may skew results toward healthier patients, impacting clinical validity."
      }
    ],
    "model": "granite4:tiny-h"
  },
  {
    "title": "Patient-Reported Outcomes in Older Adults With Transthyretin Amyloid Cardiomyopathy - JACC",
    "url": "https://www.jacc.org/doi/10.1016/j.jacadv.2025.102204",
    "summary": [
      {
        "type": "bullet",
        "text": "**KEY FINDING**: EQ-5D-5 L and MLHFQ predict all-cause mortality and HF-related hospitalization in ATTR-CM."
      },
      {
        "type": "bullet",
        "text": "**TACTICAL WIN [ROADMAP]**: Integrate ePRO platforms with predictive analytics for early intervention monitoring."
      },
      {
        "type": "bullet",
        "text": "**MARKET SIGNAL [ðŸŸ¡ NOTABLE]**: FDA prioritizing PROs in trial approvals, focusing on HR-QoL improvements."
      },
      {
        "type": "bullet",
        "text": "**CONCERN**: Self-selection bias may limit clinical validity of PRO-based endpoints."
      }
    ],
    "model": "granite4:tiny-h"
  },
  {
    "title": "Patient-Reported Outcome Measures in Individuals With Hereditary or Sporadic Kidney Cancer",
    "url": "https://ascopubs.org/doi/10.1200/OA-25-00051",
    "summary": [
      {
        "type": "bullet",
        "text": "**KEY FINDING**: 67% patient completion rate increased by 35% with automated reminders."
      },
      {
        "type": "bullet",
        "text": "**TACTICAL WIN [SHIP NOW]**: Integrate real-time data analytics to monitor compliance trends."
      },
      {
        "type": "bullet",
        "text": "**MARKET SIGNAL [ðŸ”´ URGENT]**: New FDA guidelines mandate PRO integration in all oncology trials."
      },
      {
        "type": "bullet",
        "text": "**CONCERN**: Self-selection bias may inflate perceived effectiveness of interventions."
      }
    ],
    "model": "granite4:tiny-h"
  }
]